| 3′ UTR | 3′ untranslated region |
| A-to-I | adenosine-to-inosine |
| Ago | Argonaute |
| ALCL | anaplastic large cell lymphoma |
| AML | acute myelogenous leukemia |
| ATTR-FAP | transthyretin familial amyloid polyneuropathy |
| BET | bromodomain and extraterminal |
| C19MC | Chr19q13.41 miRNA cluster |
| CAR | chimeric antigen receptor |
| ceRBP | cross-talk with endogenous RNA binding protein |
| ceRNA | competing endogenous RNA |
| ChIP-seq | chromatin immunoprecipitation-sequencing |
| CLL | chronic lymphocytic leukemia |
| CTCL | cutaneous T cell lymphoma |
| DGCR8 | DiGeorge syndrome critical region 8 |
| dsRNA | double-stranded RNA |
| eCLIP | enhanced UV crosslinking followed by immunoprecipitation |
| EDICT | endothelial dystrophy, iris hypoplasia, congenital cataract, and stromal thinning |
| EGFR | epidermal growth factor receptor |
| EMT | epithelial–mesenchymal transition |
| EMTR | embryonal tumors with multilayered rosettes |
| ESC | embryonic stem cell |
| GWAS | genome-wide association study |
| HDAC | histone deacetylase |
| IL-6 | interleukin-6 |
| iNOS | inducible nitric oxide synthase |
| m6A | N6-methyladenosine |
| m7G | 7-methylguanosine |
| METTL | methyltransferase-like |
| miRNA | microRNA |
| ncNRA | non-coding RNA |
| NPM-ALK | nucleophosmin-anaplastic lymphoma kinase |
| pre-miRNA | precursor miRNA |
| pri-miRNA | primary miRNA |
| RBP | RNA-binding protein |
| RISC | RNA-induced silencing complex |
| RNAi | RNA interference |
| RTK | receptor tyrosine kinase |
| SE | super-enhancer |
| SE-miRNA | super-enhancer-associated miRNA |
| SED | spondyloepiphyseal dysplasia |
| siRNA | small interfering RNA |
| SLAM-seq | Thiol (SH)-linked alkylation for the metabolic sequencing of RNA |
| STAT3 | signal transducer and activator of transcription 3 |
| TGF-β | transforming growth factor-β |
| Th | T-helper |
| TNBC | triple-negative breast cancer |
| TSSmiRNA | transcription start site miRNA |
| TβRII | TGF-β type II receptor |
| XPO5 | exportin-5 |